Franklin Resources
FENC icon

Franklin Resources’s Fennec Pharmaceuticals FENC Stock Holding History

Franklin Resources’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,978
Closed -$159K – 3168
2025
Q3 		$159K Buy
16,978
+594
+4% +$5.14K ﹤0.01% 2875
2025
Q2 		$136K Buy
16,384
+396
+2% +$2.71K ﹤0.01% 2821
2025
Q1 		$97.4K Buy
15,988
+102
+0.6% +$655 ﹤0.01% 2811
2024
Q4 		$100K Buy
15,886
+1,087
+7% +$5.57K ﹤0.01% 2752
2024
Q3 		$67.2K Buy
14,799
+2,330
+19% +$13.5K ﹤0.01% 2776
2024
Q2 		$76.2K Buy
+12,469
New +$104K ﹤0.01% 2702

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's FENC Position: Q4 2025 in Review

Franklin Resources sold out of Fennec Pharmaceuticals (FENC) in Q4 2025, closing a stake of 16,978 shares — an estimated $159K sold.

Franklin Resources first reported a position in FENC in Q2 2024 and held it in 6 quarters. The position peaked at $159K in Q3 2025. 96 funds tracked by Wall St. Rank hold FENC as of Q4 2025.

  • Franklin Resources reported no remaining Fennec Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Franklin Resources sold 16,978 Fennec Pharmaceuticals shares in Q4 2025, an estimated $159K.
  • Franklin Resources first reported a position in Fennec Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • Franklin Resources's Fennec Pharmaceuticals position peaked at $159K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.